Recently, PTPRK-RSPO3 (P:R) fusion also contributes to the activation of WNT signaling and causes colorectal cancer, and this mutation is mutually exclusive with the APC mutation and is recognized as another important mutation contributing to the development of colorectal cancer [14–17]. This evidence concerns the gene PTPRK and colorectal cancer.